When we break a bone, the damage is obvious. But not every health condition in life is so clear-cut. Many ailments are ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...

Once clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

An Albuquerque hot air balloon pilot has taken on a new role of becoming his own biggest health advocate in order to get a ...

Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis ...

Although people with Crohn's disease may produce antibodies, it is unclear whether antibodies are involved in the disease process. For that reason, it's not accurate to call Crohn's disease an ...

alcohol-related liver disease, and autoimmune liver disease, bilirubin offers insight into disease severity and progression, as well as potential therapeutic implications. The metabolism of ...

California biotechnology startup Evommune has raised $115 million to advance a pair of medicines it’s developing for chronic immune conditions. The Series C funding announced Thursday will support a ...